Literature DB >> 8139628

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis.

S E Weis1, P C Slocum, F X Blais, B King, M Nunn, G B Matney, E Gomez, B H Foresman.   

Abstract

BACKGROUND: Tuberculosis has reemerged as an important public health problem, and the frequency of drug resistance is increasing. A major reason for the development of resistant infections and relapse is poor compliance with medical regimens. In Tarrant County, Texas, we initiated a program of universal directly observed treatment for tuberculosis. We report the effect of the program on the rates of primary and acquired drug resistance and relapse among patients with tuberculosis.
METHODS: We collected information on all patients with positive cultures for Mycobacterium tuberculosis in Tarrant County from January 1, 1980, through December 31, 1992. Through October 1986, patients received a traditional, unsupervised drug regimen. Beginning in November 1986, nearly all patients received therapy under direct observation by health care personnel.
RESULTS: A total of 407 episodes in which patients received traditional treatment for tuberculosis (January 1980 through October 1986) were compared with 581 episodes in which therapy was directly observed (November 1986 through December 1992). Despite higher rates of intravenous drug use and homelessness and an increasing rate of tuberculosis during this 13-year period, the frequency of primary drug resistance decreased from 13.0 percent to 6.7 percent (P < 0.001) after the institution of direct observation of therapy, and the frequency of acquired resistance declined from 14.0 percent to 2.1 percent (P < 0.001). The relapse rate decreased from 20.9 percent to 5.5 percent (P < 0.001), and the number of relapses with multidrug-resistant organisms decreased from 25 to 5 (P < 0.001).
CONCLUSIONS: The administration of therapy for M. tuberculosis infection under direct observation leads to significant reductions in the frequency of primary drug resistance, acquired drug resistance, and relapse.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139628     DOI: 10.1056/NEJM199404283301702

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  128 in total

Review 1.  Directly observed therapy (DOT) for tuberculosis: why, when, how and if?

Authors:  L P Ormerod
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Directly observed therapy and tuberculosis treatment completion. Bloch re: Bayer et al.

Authors:  A B Bloch
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

3.  Does directly observed therapy work?

Authors:  W J Burman; W el-Sadr
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

4.  Directly observed therapy for tuberculosis.

Authors:  S Marks; C Nguyen; N Qualls; Z Taylor
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

Review 5.  Immigrant women's health: Infectious diseases--Part 1. Clinical assessment, tuberculosis, hepatitis, and malaria.

Authors:  R Avery
Journal:  West J Med       Date:  2001-09

6.  Characterization of IS6110 restriction fragment length polymorphism patterns and mechanisms of antimicrobial resistance for multidrug-resistant isolates of Mycobacterium tuberculosis from a major reference hospital in Assiut, Egypt.

Authors:  S Abbadi; H G Rashed; G P Morlock; C L Woodley; O El Shanawy; R C Cooksey
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

7.  Homelessness and health.

Authors:  S W Hwang
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

Review 8.  Optimizing tuberculosis control in the inner city.

Authors:  J M FitzGerald
Journal:  CMAJ       Date:  1999-03-23       Impact factor: 8.262

9.  Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.

Authors:  Frederick L Altice; Duncan Smith-Rohrberg Maru; R Douglas Bruce; Sandra A Springer; Gerald H Friedland
Journal:  Clin Infect Dis       Date:  2007-08-13       Impact factor: 9.079

Review 10.  [Tuberculosis-current therapeutic principles].

Authors:  U Greinert; P Zabel
Journal:  Internist (Berl)       Date:  2003-11       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.